SCHEMBL12652607

SCHEMBL12652607

NS(=O)(=O)OC[C@@H]1CC[C@H](n2cnc3c(NCc4ccc(F)cc4)ncnc32)O1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR2F2 P24468 2/20 0.54
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ SLC29A1 Q99808 3/20 0.45
▸ CCNA2 P20248 1/20 0.45
▸ CDK2 P24941 1/20 0.45
▸ CDK5 Q00535 1/20 0.45
▸ CDK5R1 Q15078 1/20 0.45
▸ JAK2 O60674 1/20 0.42
▸ LTK P29376 1/20 0.42
▸ JAK3 P52333 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ ADORA2A P29274 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12567124 0.91 ABL1 (0.49) NR2F2NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL12566819 0.91 NPC1 (0.58) NR2F2NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL20008060 0.88 NR2F2 (0.54) NR2F2NPC1RAB9ASMN1; SMN2SLC29A1
SCHEMBL12566837 0.81 CCNA2 (0.43) NPC1RAB9ASMN1; SMN2CCNA2CDK2
SCHEMBL12567224 0.80 ADORA3 (0.44) NPC1RAB9ASMN1; SMN2TSHRNFKB1
SCHEMBL1796050 0.80 SLC29A1 (0.64) SLC29A1ADORA3DNPH1
SCHEMBL13773372 0.78 BCHE (0.54) SMN1; SMN2CYP3A4NFKB1BLMALDH1A1
SCHEMBL12566833 0.78 BCHE (0.41) ALDH1A1
SCHEMBL20008035 0.78 ABL1 (0.50) NR2F2NPC1RAB9ASMN1; SMN2TSHR
SCHEMBL12652414 0.78 UBA6 (0.47) NR2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951810-B2 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-05-31 — — US disclosed
Send feedback